NASDAQ$WBA

Walgreens Boots Alliance Inc · Q4 2021 earnings

Q4 2021 earnings · · Investor relations

Briefing

Walgreens' Q4 2021 earnings exceeded expectations, driven by strong operational performance and surpassing vaccination goals.

Walgreens Boots Alliance reported strong Q4 2021 results, exceeding expectations with a 12.8% increase in sales to $34.3 billion and adjusted EPS of $1.17, reflecting robust growth in both the International and United States segments. The company surpassed its COVID-19 vaccination goal, administering 13.5 million vaccinations during the quarter, and achieved over $2 billion in annual cost savings through its Transformational Cost Management Program.

  • Fourth quarter sales from continuing operations increased 12.8 percent year-over-year to $34.3 billion.
  • Fourth quarter adjusted EPS increased 29.5 percent to $1.17.
  • Walgreens surpassed COVID-19 vaccination goal, providing 13.5 million vaccinations in the quarter.
  • The Transformational Cost Management Program delivered in excess of $2 billion in annual cost savings by fiscal 2021, a year ahead of schedule.

Headline financials

Total Revenue

$34.3B

Previous: $34.7B-1.4%
EPS (adj)

$1.17

Previous: $1.02+14.7%
Capital Expenditures

$378M

Previous: $412M-8.3%
Free Cash Flow

$867M

Previous: $1.7B-49.0%
Net Income

$358M

Previous: $373M-4.0%
Operating Income

$910M

Previous: $650M+40.0%
Gross Profit

$7.5B

Previous: $6.8B+10.3%
Cash & Equivalents

$1.19B

Previous: $516M+131.2%
Total Assets

$81.3B

Previous: $87.2B-6.8%
Stock-Based Comp

$35M

Previous: $36M-2.8%

Revenue & EPS history

Walgreens · Revenue · Quarterly

$34.3B

Q4 2021-1.4%vs Q4 2020
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

Walgreens · $34.3B total across 2 segments · Q4 2021

  • U.S. Pharmacy
    $28.8B+6.7%
  • International
    $5.5B+139.1%

Forward guidance

Company leadership to discuss strategic priorities for the future and fiscal 2022 guidance at Virtual Investor Conference today

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 16 quarterly earnings reports · overlaid with Q4 2021

Historical avgQ4 2021

-0.1%

Avg return

Earnings day

+0.4%

Avg return

5 days after

-1.9%

Avg return

30 days after

53%

33 / 62 earnings

Positive

+29.1%

Q1 2025

Best reaction

-22.7%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025
Q3 2025+0.4%+1.5%+2.7%
Q2 2025-1.1%+0.5%+4.1%
Q1 2025+29.1%+36.1%+10.0%
Q4 2024+23.0%+18.7%-2.0%
Q3 2024-22.7%-26.0%-24.5%
Q2 2024-7.0%-10.9%-15.7%
Q1 2024-2.2%-0.6%-11.4%
Q4 2023+2.9%+2.1%-7.3%
Q3 2023-7.9%-10.2%-3.0%
Q2 2023+3.7%+5.0%+6.6%
Q1 2023-2.3%-2.1%-1.1%
Q4 2022+4.1%+3.8%+29.4%
Q3 2022-5.7%-5.7%-2.9%
Q2 2022-7.6%-8.4%-10.6%
Q1 2022-0.3%+0.6%-10.0%
Q4 2021+3.5%+1.5%+4.8%
Q3 2021-8.4%
Q2 2021+3.3%
Q1 2021+5.1%
Q4 2020+4.2%
Q3 2020-5.1%
Q2 2020-5.4%
Q1 2020-7.8%
Q4 2019+1.5%
Q3 2019+4.4%
Q2 2019-13.6%
Q1 2019-8.2%
Q4 2018+1.6%
Q3 2018-9.4%
Q2 2018-0.7%
Q1 2018-3.4%
Q4 2017-0.3%
Q3 2017+1.6%
Q2 2017-1.0%
Q1 2017+0.1%
Q4 2016+5.7%
Q3 2016-3.6%
Q2 2016-3.0%
Q1 2016+1.8%
Q4 2015-11.9%
Q3 2015+8.4%
Q1 2014+4.9%
Q2 2015+4.9%
Q4 2013+4.9%
Q1 2015+3.2%
Q4 2014-0.9%
Q3 2014+0.6%
Q2 2014+1.0%
Q3 2013-1.0%
Q2 2013+0.4%
Q1 2013+1.6%
Q4 2012+1.4%
Q3 2012-3.2%
Q2 2012-1.9%
Q1 2012+4.1%
Q4 2011+0.4%
Q3 2011-0.9%
Q2 2011+1.8%
Q1 2010+2.5%
Q4 2010+1.8%
Q3 2010-0.1%
Q2 2009+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro